European cannabis companies start IPO planning as US considers looser rules

Q: How long will it take to read this news story?

The story "European cannabis companies start IPO planning as US considers looser rules" has 707 words across 27 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "European cannabis companies start IPO planning as US considers looser rules" was covered 2 days ago by Financial Times, a news publisher based in United States.

Q: How trustworthy is 'Financial Times' news outlet?

Financial Times is a fully independent (privately-owned) news outlet established in 1888 that covers mostly markets, finance, and investing news. The outlet is headquartered in United States and publishes an average of 12 news stories per day. It's most recent story was published 13 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21620698</li><li>URL: https://beamstart.com/news/european-cannabis-companies-start-ipo-172101852728</li></ul>

Financial Times 2d ago

European cannabis companies start IPO planning as US considers looser rules - Financial Times

Quick Summary:

However, founder and executive chair Boris Jordan believes this is mainly because of strict regulation.“Governments need to decide if cannabis is going to be legal or is it illegal.

If it is reclassified by the DEA, this could reduce taxes on state-legal cannabis businesses — where the effective tax rate is often 70 per cent or more — in the world’s biggest cannabis market.

The US Drug Enforcement Administration in May published a notice of proposed rulemaking, announcing its intention to remove cannabis from its list of the most dangerous drugs and recognise its medicinal use.